BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19535778)

  • 1. Are we getting closer to molecular population screening for colorectal cancer?
    Rennert G
    J Natl Cancer Inst; 2009 Jul; 101(13):902-3. PubMed ID: 19535778
    [No Abstract]   [Full Text] [Related]  

  • 2. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stool test for colorectal cancer screening--it's time to move!
    Loitsch SM; Shastri Y; Stein J
    Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible?
    Brenner DE; Rennert G
    J Natl Cancer Inst; 2005 Aug; 97(15):1107-9. PubMed ID: 16077063
    [No Abstract]   [Full Text] [Related]  

  • 5. Fecal pyruvate kinase-M2 (tumor M2-PK) measurement: a new screening concept for colorectal cancer.
    Ewald N; Schaller M; Bayer M; Akinci A; Bretzel RG; Kloer HU; Hardt PD
    Anticancer Res; 2007; 27(4A):1949-52. PubMed ID: 17649802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fecal methylated DNA for the detection of colorectal cancer].
    von Delius S; Jung A; Schmid RM
    Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems and prospects of non-invasive screening for colorectal cancer].
    Maev IV; Govorun VM; Kucheriavyĭ IuA; Golubev NN; Generozov EV; Maslov VV; LiubeznovA IIu; Kostin PA
    Klin Med (Mosk); 2009; 87(7):10-6. PubMed ID: 19705783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Future perspectives in screening for colorectal cancer].
    Kronborg O
    Ugeskr Laeger; 2005 Oct; 167(44):4193-4. PubMed ID: 16266579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New stool screening tests for colorectal cancer.
    Young GP; Cole S
    Digestion; 2007; 76(1):26-33. PubMed ID: 17947816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which colorectal cancer screening test is best?
    Mandel JS
    J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
    [No Abstract]   [Full Text] [Related]  

  • 11. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation changes in faecal DNA: a marker for colorectal cancer screening?
    Müller HM; Oberwalder M; Fiegl H; Morandell M; Goebel G; Zitt M; Mühlthaler M; Ofner D; Margreiter R; Widschwendter M
    Lancet; 2004 Apr; 363(9417):1283-5. PubMed ID: 15094274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stool-based DNA tests for colorectal cancer: clinical potential and early results.
    Ahlquist DA
    Rev Gastroenterol Disord; 2002; 2 Suppl 1():S20-6. PubMed ID: 12439395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and prevention of colon cancer: colonoscopy, virtual colonoscopy, and DNA stool tests.
    Lidofsky S
    Med Health R I; 2005 Mar; 88(3):82-5. PubMed ID: 15915780
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular stool screening for colorectal cancer.
    Mak T; Lalloo F; Evans DG; Hill J
    Br J Surg; 2004 Jul; 91(7):790-800. PubMed ID: 15227685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening with a fecal multitarget DNA test.
    Young GP; Worthley DL
    Gastroenterology; 2005 Aug; 129(2):757-9; discussion 759. PubMed ID: 16083732
    [No Abstract]   [Full Text] [Related]  

  • 18. Stool test for colorectal cancer screening: what is going on?
    Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
    Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation stool DNA testing: expanding the scope.
    Ahlquist DA
    Gastroenterology; 2009 Jun; 136(7):2068-73. PubMed ID: 19379748
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular screening testing for colorectal cancer.
    Levin B
    Clin Cancer Res; 2006 Sep; 12(17):5014-7. PubMed ID: 16951215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.